🇺🇸

US SEC Filing Intelligence

· daily

Contract Deobligations Alert — April 12, 2026

Contract deobligations alert for April 12, 2026, aggregates $1,954,256,236 in total obligations across two actions, entirely civilian with 0/2 defense-related and average signal strength 5.5/10. The dominant event is Department of Commerce's $1,826,088,581 deobligation involving L3Harris Technologies, Inc. (2009 award), the highest-conviction bullish signal (strength 7/10, materiality 8/10). Department of Education's $128,167,655 deobligation to Missouri Higher Education Loan Authority (March 31, 2026 award) carries a neutral signal (strength 4/10, materiality 4/10) in student loan servicing. Civilian agencies (Commerce, Education) drive the theme of obligation adjustments. Key watch item: $0 outlays to date on Missouri Higher Education Loan Authority contract, with options expandable to $295,652,367.

2 total filings
· daily

Contract Option Exercises — April 12, 2026

Two civilian contract option exercises totaling $1,954,256,236 in obligations occurred from April 12 to April 12, 2026, with 0 defense-related awards out of 2 total. The dominant theme is large-scale civilian agency commitments, led by Department of Commerce's $1.83B award to L3HARRIS TECHNOLOGIES, INC. and a smaller $128M Department of Education award to MISSOURI HIGHER EDUCATION LOAN AUTHORITY for student loan servicing. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its high materiality (8/10) $1.83B option exercise despite unknowns on revenue impact. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M award, currently at $0 with options to $295M.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — April 12, 2026

The Federal IT & Cybersecurity contracts stream saw a single $1,826,088,581 obligation from April 12, 2026 to April 12, 2026, entirely civilian with 0/1 defense-related awards. Department of Commerce dominated with a $1.83B award to L3HARRIS TECHNOLOGIES, INC., despite the summary labeling it a defense contract. This represents the highest-conviction bullish signal (7/10 strength, 8/10 materiality) for L3Harris in civilian IT/cybersecurity exposure. Key risk includes unknown competition signals and pricing risk, potentially exposing the award to protests or cost overruns. Investors should watch L3Harris (LHX) for civilian revenue diversification amid sparse details on contract moat or sector alignment.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — April 12, 2026

Two civilian mega contracts totaling $1,954,256,236 in obligations were awarded, with 0/2 defense-related and a split of $1.83B from Department of Commerce to L3HARRIS TECHNOLOGIES, INC. and $128M from Department of Education to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. The dominant theme is civilian agency spending on unspecified services (L3Harris) and student loan servicing (Missouri). Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. on its $1.83B award, signaling strong position in Commerce procurements. Key watch item is MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $0 outlays to date and potential exercises of options expanding to $295M.

2 total filings
· daily

High-Value Federal Grants ($5M+) — April 12, 2026

High-value federal grants totaling $1,954,256,236 were analyzed for the period April 12, 2026, with a 0/2 defense-related split, entirely civilian-focused. The dominant theme is Department of Commerce awarding $1.83B to L3HARRIS TECHNOLOGIES, INC., dwarfing the $128M Department of Education grant to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its massive $1.83B obligation, signaling sustained civilian revenue stream despite the 2009 award date. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M contract, currently at $0 outlayed, with options to $295M.

2 total filings
· daily

General Federal Contracts — April 12, 2026

The two contracts totaling $1,954,256,236 in obligations are entirely civilian (0/2 defense-related), dominated by a massive $1.83B award to L3Harris Technologies, Inc. from the Department of Commerce. This overshadows the smaller $128M obligation to Missouri Higher Education Loan Authority from the Department of Education for student loan servicing. The highest-conviction signal is bullish for L3Harris, reflecting strong materiality (8/10) in a large-scale civilian contract labeled as defense-related. A key watch item is outlay progress on the Missouri Higher Education Loan Authority contract, currently at $0 despite $128M obligated, with options to expand to $295M.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — April 11, 2026

The analyzed contracts total $173,694,639 in obligations, representing a fully civilian award with 0/1 defense-related, dominated by the Department of State's AQM Momentum office for overseas construction. BL Harbert International LLC secured this single firm fixed-price contract via full and open competition for the $173,694,639 NEC - Podgorica Montenegro project under NAICS 236220, signaling neutral investment implications with average strength 4/10 and materiality 3/10. The highest-conviction signal is neutral capability in commercial/institutional building construction amid a 7.5-year performance period to March 2027. No dominant sector trends emerge from this lone contract. Key risk is high pricing risk under firm fixed-price terms with $0 outlayed to date.

1 total filings
· daily

VA Healthcare & Services Contracts — April 11, 2026

The VA Healthcare & Services Contracts stream delivered a single $518,959,505 obligation to ORACLE HEALTH GOVERNMENT SERVICES, INC., representing a 100% civilian award with zero defense-related activity during the April 11, 2026 period. This firm fixed-price, non-competed delivery order for EHRM Operations under PSC DA01 underscores VA's commitment to multi-year IT systems support, with a bullish signal driven by the substantial $518,959,505 obligation and potential upside to $632,834,475 including options. The highest-conviction signal favors ORACLE HEALTH GOVERNMENT SERVICES, INC. in stable VA IT services, highlighting its role in electronic health record modernization. A key risk is the current $0 outlays with high pricing risk under firm fixed price terms, warranting close monitoring of outlay progress and option exercises through the 2027-04-10 end date.

1 total filings
· daily

New Federal Contractors — April 11, 2026

Three new federal contracts totaling $1,236,299,978 in obligations, with 1/3 defense-related, highlight civilian agency IT and construction spending via GSA, VA, and Department of State awards to Leidos, Inc. ($543.6M), Oracle Health Government Services, Inc. ($519.0M), and BL Harbert International LLC ($173.7M). Dominant theme is mature civilian IT delivery orders with significant backlog but zero or negative outlays to date. Highest-conviction bullish signal is Oracle's $519M VA EHRM operations contract (materiality 8/10, strength 7/10), signaling stable multi-year revenue in VA IT services. Key risk is high pricing risk on firm-fixed-price structures for Oracle and BL Harbert, compounded by unexercised options and $0 outlays across all contracts. Watch outlay progress and option exercises through 2027 end dates.

3 total filings
· daily

Significant Contract Modifications ($10M+) — April 11, 2026

Significant contract modifications totaling $1,236,299,978 from April 11, 2026, feature 1/3 defense-related obligations amid predominantly civilian IT and construction sectors. Dominant themes center on GSA and VA IT delivery orders, with Leidos ($543.6M) and Oracle Health Government Services ($519.0M) providing the highest materiality bullish signals for funded backlogs in mature multi-year contracts. BL Harbert International's $173.7M State Department construction award adds neutral exposure to overseas projects. Highest-conviction signal is Oracle's $519M VA EHRM operations delivery order (materiality 8/10, strength 7/10), signaling stable VA IT demand. Key risk: $0 outlays on Oracle and BL Harbert contracts plus Leidos' negative $-1.7M outlay flag execution delays and uncertain revenue ramps.

3 total filings
· daily

Contract Deobligations Alert — April 11, 2026

Three contract deobligations totaling $1,236,299,978 in obligations highlight funded backlogs in civilian IT services, with 1/3 defense-related (VA) and 2/3 pure civilian (GSA, State Department), dominated by large IT delivery orders to Leidos ($543.6M) and Oracle Health ($519.0M). Highest-conviction bullish signal is Oracle's $519.0M VA EHRM operations award (strength 7/10, materiality 8/10), signaling multi-year VA IT stability through 2027 despite $0 outlay. Leidos' $543.6M GSA IT contract adds mature backlog upside to $729.6M, while BL Harbert's $173.7M State Department construction remains neutral. Key risk is stalled execution with Leidos' negative $-1.7M outlay and $0 progress on Oracle/BL Harbert, vulnerable to deobligation in a CR environment. Watch outlay ramps and option exercises across all three into FY2026-2027.

3 total filings
· daily

Contract Option Exercises — April 11, 2026

Option exercises across three contracts total $1,236,299,978 in obligations, with 1/3 defense-related (VA EHRM via Oracle) and the remainder civilian (GSA IT via Leidos and State construction via BL Harbert). Dominant theme is multi-year civilian IT delivery orders from GSA and VA, signaling backlog addition for Leidos Holdings (LDOS) and Oracle (ORCL) in stable federal tech services. Highest-conviction bullish signal is Oracle's $518.96M VA EHRM award (materiality 8/10), providing ~$104M annual revenue potential through 2027 amid zero outlay to date. Leidos' $543.65M GSA IT order adds funded backlog nearing end-of-life in 2024, while BL Harbert's $173.69M State construction remains neutral with low materiality. Key risk is execution on unspent obligations ($0 outlay for Oracle and BL Harbert; negative for Leidos) and high firm-fixed-price risks on Oracle and BL Harbert contracts.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — April 11, 2026

Two major civilian IT contracts totaling $1,062,605,338 in obligations highlight backlog addition for Leidos ($543.6M from GSA) and Oracle Health Government Services ($519.0M from VA), with approximately 1/2 defense-related via VA's EHRM operations. The dominant theme is stable, multi-year civilian agency IT services delivery orders under NAICS 541512, emphasizing backlog for large incumbents. Highest-conviction bullish signal is Oracle's $519M firm-fixed-price, non-competed VA award (materiality 8/10, strength 7/10), signaling entrenched positioning in VA tech. Leidos adds $544M GSA cost-plus backlog nearing end in 2024. Key risk is zero/negative outlays to date on both, with Oracle's high pricing risk under firm-fixed terms.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — April 11, 2026

Three mega contracts totaling $1,236,299,978 in obligations were analyzed, with 1/3 defense-related (~$412M) and 2/3 civilian (~$824M), dominated by civilian IT services awards to Leidos ($543.6M GSA) and Oracle Health ($519M VA). The highest-conviction bullish signal is Oracle Health Government Services' $518.9M VA EHRM delivery order (strength 7/10, materiality 8/10), signaling stable multi-year backlog in VA IT amid no outlays to date. Leidos' GSA IT contract adds $543.6M funded backlog nearing end in 2024, while BL Harbert's $173.7M State construction remains neutral. Key risk is $0 outlays on Oracle and BL Harbert contracts, plus Leidos' negative $-1.7M outlay, warranting watches on spending progress and option exercises.

3 total filings
· daily

High-Value Federal Grants ($5M+) — April 11, 2026

Three high-value federal grants totaling $1,236,299,978 were analyzed for the period April 11, 2026, with 1/3 defense-related (VA EHRM IT services) and 2/3 civilian (GSA IT and State construction). Dominant themes center on civilian IT services via GSA and VA, with Oracle Health Government Services, Inc. securing the highest-materiality $518.9M VA delivery order (bullish, 8/10 materiality). Leidos, Inc. adds a $543.6M GSA IT contract (bullish, 7/10 materiality), while BL Harbert International LLC's $173.7M State construction award remains neutral (3/10 materiality). Highest-conviction bullish signal is Oracle's non-competed VA EHRM operations contract with $632.8M potential. Key risk: $0 outlays across Oracle and BL Harbert contracts, plus Leidos' negative $-1.7M outlay, signaling potential execution delays.

3 total filings
· daily

General Federal Contracts — April 11, 2026

Across three civilian-focused contracts totaling $1,236,299,978 in obligations (1/3 defense-related per aggregate, primarily via VA IT), dominant themes emerge in GSA and VA IT services alongside State Department construction, with Leidos ($543.6M GSA) and Oracle Health ($519.0M VA) driving the bulk of value. Highest-conviction bullish signal is Oracle's $518.9M VA EHRM delivery order (materiality 8/10), signaling stable multi-year IT backlog through 2027 amid zero outlay to date. Leidos adds mature GSA IT backlog nearing end in 2024 with negative outlay risk, while BL Harbert's $173.7M State construction remains neutral with no outlays. Key risk is zero or negative outlays across two contracts (Oracle, BL Harbert), warranting watches on funding progress and option exercises. Overall average signal strength of 5.7/10 supports measured exposure to LDOS and ORCL in civilian government IT.

3 total filings
· daily

Biotech Small-Cap Approvals — April 10, 2026

The FDA approved 17 Other (fallback) products from April 6-8, 2026, with zero NMEs, biosimilars, or label expansions per classification, all carrying neutral signals (strength/materiality 5/10). A dominant theme emerged with 13 approvals for dapagliflozin across small-cap sponsors including Lupin Ltd, Cipla Ltd (x2 listings), Teva Pharms USA (x2), Macleods Pharms Ltd, Alkem Labs Ltd, Micro Labs, MSN (x2), Aurobindo Pharma (combo with metformin), Sun Pharm, and Aizant, signaling a generic entry wave in SGLT2 inhibitors for diabetes/CVD indications. Single approvals included progesterone (Glenmark Pharms Ltd), emtricitabine (Macleods Pharms Ltd), ivermectin (Ajanta Pharma Ltd), and nitrofurantoin (Creekwood Pharms). Highest-conviction signal: dapagliflozin cluster bullish for entrant sponsors' execution but risks originator erosion (30-60% potential over 2-3 years); balanced by high competition. Key risk/watch item: oversupply-driven pricing pressure on dapagliflozin entrants.

17 total filings
· daily

New Drug Approvals (Original) — April 10, 2026

FDA approvals from April 6-8, 2026 totaled 17 'other' designations (0 NMEs, 0 biosimilars, 0 label expansions per mix breakdown), all flagged as neutral signals despite individual analyses describing them as biosimilar approvals for small-molecule generics. A dominant cluster emerged with 13 DAPAGLIFLOZIN-focused approvals (12 standalone + 1 DAPAGLIFLOZIN/METFORMIN HYDROCHLORIDE combo) by 11 sponsors, signaling intense generic entry in the SGLT2 inhibitor class for diabetes/CVD, alongside isolated approvals for PROGESTERONE (GLENMARK PHARMS LTD), EMTRICITABINE (MACLEODS PHARMS LTD), IVERMECTIN (AJANTA PHARMA LTD), and NITROFURANTOIN (CREEKWOOD PHARMS). Highest-conviction signal: DAPAGLIFLOZIN biosimilars for CIPLA LTD (x2), TEVA PHARMS USA (x2), and MSN (x2), bullish for entrant pipeline execution and US revenue upside, bearish for originator facing erosion. No NME innovation or pipeline strength signals evident. Key risk/watch item: Competitive saturation among DAPAGLIFLOZIN entrants risking pricing compression, with all peak sales, exclusivity, and pricing NOT_DISCLOSED.

17 total filings
· daily

Federal Construction & Infrastructure Contracts — April 10, 2026

These three civilian federal construction contracts total $622,154,216 in obligations with zero defense-related awards, dominated by a massive $519.3 million DOJ/FBI delivery order to Brasfield & Gorrie LLC for the Academic Zone Design-Build Project at Redstone Arsenal. The highest-conviction bullish signal stems from Brasfield & Gorrie LLC's long-term 6.7-year fixed-price commitment with $99.4 million already outlayed, projecting ~$77.8 million annual revenue. Remaining awards to Clark Construction Group LLC ($51.6 million HHS grant) and Archer Western Construction LLC ($51.3 million DOI water infrastructure, nearly fully disbursed at $51.0 million outlayed) are neutral signals in disparate civilian infrastructure sectors. Key risk: Archer Western's high contract pricing risk and impending April 2025 completion, with watch on Brasfield & Gorrie outlay progress beyond $99.4 million.

3 total filings
· daily

DHS Homeland Security Contracts — April 10, 2026

DHS awarded two civilian contracts totaling $142,112,132 with no defense exposure, focused on U.S. Customs and Border Protection (CBP) IT network management and U.S. Immigration and Customs Enforcement (ICE) detention services. The highest-conviction signal is bullish on THE GEO GROUP, INC. for its $59,993,453 firm fixed price delivery order, signaling sustained ICE detention needs with $47,096,715 already outlayed in under six months. PERATON ENTERPRISE SOLUTIONS LLC's $82,118,679 ongoing order provides revenue visibility through 2027 but is neutral due to 97.6% subawards of outlayed funds. Dominant theme is DHS operational sustainment in IT and facilities support. Key risk is Peraton's high subcontracting exposure and GEO's firm fixed price performance risk through October 2025.

2 total filings